| Sandoz Pharmaceuticals AG - Bupropion XR Sandoz 150 mg, Retardtabletten | | 68628 | | 01 | | Bupropion XR Sandoz 150 mg | | Retardtabletten | | N06AX12 | | Bupropion | | 12.12.2023 | | |
| | Composition | | bupropioni hydrochloridum 150 mg, povidonum K 90, acidum hydrochloridum, natrii stearylis fumaras corresp. natrium 0.309 mg, ethylcellulosum, hydroxypropylcellulosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, silica colloidalis anhydrica, macrogolum 1500, triethylis citras, Überzug: hypromellosum, macrogolum 400, macrogolum 8000, pro compresso obducto. | | Packungsbestandteile | | Comprimés retards | | | | Principe actif | Concentr. |
|---|
| Bupropion Hydrochloride | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Methacrylici | | | | Acidum Hydrochloridum | | | | Ethylcellulosum | | | | Ethylis Acrylatis Polymerisatum | | | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Macrogol | 8000 | | | Natrii Stearylis Fumaras | | | | Povidonum K | 90 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triethylis Citras | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 10 | DDP | DDP | B | | Non | | 002 | 30 | DDP | DDP | B | | Non |
|
|
